Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2869
Selected: 0
NCT IDTitle
NCT02990611Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy
NCT04730544Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
NCT03267498Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
NCT01137578Pediatric Catheter-related Thrombosis Imaging Study
NCT00291707Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer
NCT01188278Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey
NCT01236235Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
NCT02045693Drug Interaction & Methadone & Buprenorphine
NCT06073847A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis
NCT02769078Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
NCT03348904Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
NCT02157506A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
NCT02046733Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
NCT04090710SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
NCT03317327REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors
NCT01621490PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma
NCT01454479A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
NCT00312598Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
NCT01670058Pattern Of Use Of Belatacept In US Transplant Recipients
NCT00036621A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
NCT00683852A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
NCT03695250BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
NCT03316274Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
NCT01409174IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
NCT00162279The Study of Abatacept in Combination With Etanercept
NCT06211179A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants
NCT03739788An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants
NCT03739619Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
NCT02243371GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab
NCT03486899A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
NCT04200963A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
NCT00869349Living Well With Rheumatoid Arthritis
NCT00048581Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
NCT07325136A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT00237471Impact of Tight Glycaemic Control in Acute Myocardial Infarction
NCT03324633Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV
NCT03196206Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment
NCT00162448A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators
NCT03196557A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject
NCT03639714A Study of a Personalized Neoantigen Cancer Vaccine
NCT04186871Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
NCT04066114Treg Modulation With CD28 and IL-6 Receptor Antagonists
NCT06180863Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
NCT00211263Bipolar Disorder Research Study for Ages 12 and Older
NCT00567099Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
NCT07017699A Study to Assess Deucravacitinib Safety in Pregnancy
NCT02750514An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
NCT06499298Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer
NCT01106534XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
NCT00564187Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice